IPARINTERPARFUMS INC
Health Care
Net Income (Loss) Attributable to Parent revised up 24.9% for FY 2022
This is the 3rd largest revision in IPAR's history.
Net Income (Loss) Attributable to Parent·FY 2022
Major restatement$151M▲ 24.9%
was$120.9M
Revised up. Any P/E built on the original was 19.9% too high.
Verify against SEC filingsShow
As reported$120.9M
Accepted 2023-02-280001753926-23-000213
Restated$151M
Accepted 2026-07-310001753926-26-001295
NetIncome · reported 4 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time IPAR — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.